Skip to main content

DHSC Annual Report & Accounts 2022-23


In 2023, the Committee reported that the Department for Health & Social Care (DHSC) had overpaid and overordered £14.9 billion of inventory, which included PPE (£9.9 billion), COVID-19 medicines (£2.6 billion) and COVID-19 vaccines (£1.9 billion). Vast quantities of unusable and unneeded PPE were in storage awaiting disposal by recycling or burning, at significant cost to the taxpayer.

The Committee also found that the UK Health Security Agency (UKHSA) was set up with financial controls so poor that it could not be established whether its transactions were applied to the purposes laid out for it by Parliament. UKHSA’s consumption of £3.3 billion worth of inventory transferred from NHS Test and Trace could not be verified by proper financial records.

Based on the National Audit Office’s (NAO) report into the DHSC’s Annual Report & Accounts 2022-23, the Committee will take evidence from senior DHSC officials on subjects including:

  • Progress in recovering financial control following the COVID-19 pandemic;
  • Progress at UKHSA;
  • Continuing issues with timeliness of local NHS audits.

If you have evidence on these issues, please submit it here by 23:59 on Wednesday 28 February 2024.

Please look at the requirements for written evidence submissions and note that the Committee cannot accept material as evidence that is published elsewhere.